Callan Jmb INC Form 4 insider transactions

Callan JMB Inc. director Gerald Dial reported transactions involving common stock and stock options, including the acquisition of 10,000 shares and the grant of an option to purchase 25,000 shares.

CALLAN JMB Inc. Director and Chief Medical Officer David J. Croyle acquired 10,195 shares of common stock at $1.75 per share.

CALLAN JMB Director Gerald Dial reported acquiring 2,000 shares of common stock and holding 25,000 stock options.

CALLAN JMB INC. CEO, Chairman, and President Wayne D. Williams purchased 5,000 shares of common stock at $1.73 per share.

CALLAN JMB INC. CEO Wayne D. Williams filed a Form 4 disclosing planned common stock purchases in December 2025 under a Rule 10b5-1 trading plan.

CALLAN JMB CEO Wayne D. Williams acquired additional common stock through indirect holdings in December 2025.

A director at Callan JMB Inc. reported recent purchases of common stock and the grant of stock options.

David J. Croyle, Chief Medical Officer and a 10% owner of Callan JMB Inc., acquired 25,000 shares of common stock for $4.50 per share on March 27, 2025, increasing his indirect holdings through a Rollover IRA.

Wayne D. Williams, CEO and President of Callan JMB Inc., reports acquiring shares of common stock both directly and indirectly through affiliated entities.

David J. Croyle, Chief Medical Officer and 10% owner of Callan JMB Inc., reports acquiring additional shares of common stock.